Search Results - "Shamskhou, Elya A."

Site-specific regulation of Th2 differentiation within lymph node microenvironments by Lyons-Cohen, Miranda R, Shamskhou, Elya A, Gerner, Michael Y

“…T helper 2 (Th2) responses protect against pathogens while also driving allergic inflammation, yet how large-scale Th2 responses are generated in tissue…”
Get full text

Anatomic, genetic and functional properties of the retinal circulation in pulmonary hypertension by Nickel, Nils P., Shamskhou, Elya A., Razeen, Moataz A., Condon, David F., Messentier Louro, Louise A., Dubra, Alfredo, Liao, Yaping J., Zamanian, Roham T., Yuan, Ke, Perez, Vinicio A. de Jesus

Get full text

Loss of Endothelium-Derived Wnt5a Is Associated With Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension by Yuan, Ke, Shamskhou, Elya A, Orcholski, Mark E, Nathan, Abinaya, Reddy, Sushma, Honda, Hiroaki, Mani, Vigneshwaran, Zeng, Yitian, Ozen, Mehmet O, Wang, Lingli, Demirci, Utkan, Tian, Wen, Nicolls, Mark R, de Jesus Perez, Vinicio A

“…BACKGROUND:Pulmonary arterial hypertension (PAH) is a life-threatening disorder of the pulmonary circulation associated with loss and impaired regeneration of…”
Get full text

Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice by Shamskhou, Elya A., Kratochvil, Michael J., Orcholski, Mark E., Nagy, Nadine, Kaber, Gernot, Steen, Emily, Balaji, Swathi, Yuan, Ke, Keswani, Sundeep, Danielson, Ben, Gao, Max, Medina, Carlos, Nathan, Abinaya, Chakraborty, Ananya, Bollyky, Paul L., De Jesus Perez, Vinicio A.

“…Idiopathic pulmonary fibrosis (IPF) is a life-threatening progressive lung disorder with limited therapeutic options. While interleukin-10 (IL-10) is a potent…”
Get full text

Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension by Chakraborty, Ananya, Nathan, Abinaya, Orcholski, Mark, Agarwal, Stuti, Shamskhou, Elya A, Auer, Natasha, Mitra, Ankita, Guardado, Eleana Stephanie, Swaminathan, Gowri, Condon, David F, Yu, Joyce, McCarra, Matthew, Juul, Nicholas H, Mallory, Alden, Guzman-Hernandez, Roberto A, Yuan, Ke, Rojas, Vanesa, Crossno, Joseph T, Yung, Lai-Ming, Yu, Paul B, Spencer, Thomas, Winn, Robert A, Frump, Andrea, Karoor, Vijaya, Lahm, Tim, Hedlin, Haley, Fineman, Jeffrey R, Lafyatis, Robert, Knutsen, Carsten N F, Alvira, Cristina M, Cornfield, David N, de Jesus Perez, Vinicio A

“…Pulmonary arterial hypertension (PAH) is characterised by loss of microvessels. The Wnt pathways control pulmonary angiogenesis but their role in PAH is…”
Get more information

EMAPII: A Key Player in HIV-Nef-induced Pulmonary Vasculopathy by Shamskhou, Elya A, Verghese, Leah, Yuan, Ke, de Jesus Perez, Vinicio A

“…In a series of elegant studies, the authors show that incubation with either T cells or EVs containing HIV-Nef promotes EMAPII surface expression in human lung…”
Get full text

Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension by Orcholski, Mark E, Khurshudyan, Artyom, Shamskhou, Elya A, Yuan, Ke, Chen, Ian Y, Kodani, Sean D, Morisseau, Christophe, Hammock, Bruce D, Hong, Ellen M, Alexandrova, Ludmila, Alastalo, Tero-Pekka, Berry, Gerald, Zamanian, Roham T, de Jesus Perez, Vinicio A

“…Pulmonary arterial hypertension is a complication of methamphetamine use (METH-PAH), but the pathogenic mechanisms are unknown. Given that cytochrome P450 2D6…”
Get more information

LOSS OF ENDOTHELIAL DERIVED WNT5A IS ASSOCIATED WITH REDUCED PERICYTE RECRUITMENT AND SMALL VESSEL LOSS IN PULMONARY ARTERIAL HYPERTENSION by Yuan, Ke, Shamskhou, Elya A., Orcholski, Mark E., Nathan, Abinaya, Reddy, Sushma, Honda, Hiroaki, Mani, Vigneshwaran, Zeng, Yitian, Ozen, Mehmet O., Wang, Lingli, Demirci, Utkan, Tian, Wen, Nicolls, Mark R., de Jesus Perez, Vinicio A.

Get full text